“deals” Archives

in
Entry Author Date Location
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug 07/29/20 Europe
Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology 07/29/20 Boston
Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding 07/21/20 National
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War 06/24/20 San Diego
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug 06/18/20 Seattle
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
Page 1 of 297 next page »